 Catherine Proenza
Concepts (184)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sinoatrial Node | 14 | 2022 | 27 | 5.240 |
Why?
| | Myocytes, Cardiac | 9 | 2022 | 513 | 2.380 |
Why?
| | Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels | 15 | 2024 | 36 | 2.180 |
Why?
| | Cyclic AMP | 9 | 2024 | 219 | 2.020 |
Why?
| | Cyclic Nucleotide-Gated Cation Channels | 7 | 2018 | 15 | 1.770 |
Why?
| | Action Potentials | 8 | 2022 | 485 | 1.680 |
Why?
| | Muscle Cells | 4 | 2017 | 42 | 1.520 |
Why?
| | Biological Clocks | 2 | 2021 | 45 | 1.310 |
Why?
| | Heart Rate | 6 | 2022 | 802 | 1.030 |
Why?
| | Ion Channel Gating | 6 | 2012 | 91 | 1.000 |
Why?
| | Ion Channels | 8 | 2012 | 127 | 0.870 |
Why?
| | Muscle Proteins | 7 | 2024 | 239 | 0.820 |
Why?
| | Electrophysiological Phenomena | 2 | 2021 | 58 | 0.790 |
Why?
| | Membrane Potentials | 7 | 2020 | 283 | 0.790 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 3 | 2013 | 129 | 0.780 |
Why?
| | Heart | 4 | 2022 | 611 | 0.640 |
Why?
| | Endoplasmic Reticulum | 1 | 2020 | 265 | 0.550 |
Why?
| | Aging | 3 | 2019 | 1855 | 0.520 |
Why?
| | Statistics as Topic | 1 | 2017 | 298 | 0.500 |
Why?
| | Calcium | 7 | 2022 | 1180 | 0.490 |
Why?
| | Mice | 20 | 2022 | 17814 | 0.470 |
Why?
| | CHO Cells | 8 | 2020 | 167 | 0.470 |
Why?
| | Primary Cell Culture | 1 | 2015 | 171 | 0.440 |
Why?
| | Animals | 28 | 2024 | 37217 | 0.440 |
Why?
| | Gene Transfer Techniques | 1 | 2015 | 176 | 0.420 |
Why?
| | Protein Isoforms | 6 | 2024 | 395 | 0.390 |
Why?
| | Computational Biology | 1 | 2017 | 649 | 0.390 |
Why?
| | Ryanodine Receptor Calcium Release Channel | 3 | 2017 | 72 | 0.370 |
Why?
| | Myristic Acids | 1 | 2011 | 8 | 0.350 |
Why?
| | Cricetulus | 3 | 2020 | 110 | 0.340 |
Why?
| | Calcium Channels, L-Type | 3 | 2001 | 117 | 0.330 |
Why?
| | Mice, Inbred C57BL | 6 | 2021 | 5798 | 0.320 |
Why?
| | Potassium Channels | 8 | 2024 | 149 | 0.320 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2011 | 274 | 0.320 |
Why?
| | Sympathetic Nervous System | 1 | 2010 | 172 | 0.310 |
Why?
| | Cricetinae | 7 | 2012 | 297 | 0.300 |
Why?
| | Receptors, Adrenergic, beta | 2 | 2022 | 69 | 0.280 |
Why?
| | Patch-Clamp Techniques | 4 | 2024 | 291 | 0.280 |
Why?
| | HEK293 Cells | 3 | 2024 | 728 | 0.270 |
Why?
| | Membrane Proteins | 2 | 2024 | 1145 | 0.240 |
Why?
| | Cell Line | 5 | 2020 | 2876 | 0.230 |
Why?
| | Protein Binding | 4 | 2024 | 2225 | 0.220 |
Why?
| | Recombinant Fusion Proteins | 4 | 2012 | 663 | 0.220 |
Why?
| | Protein Structure, Tertiary | 4 | 2012 | 858 | 0.200 |
Why?
| | Mitochondrial Membrane Transport Proteins | 1 | 2022 | 43 | 0.190 |
Why?
| | Muscle, Skeletal | 4 | 2001 | 1729 | 0.190 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2024 | 208 | 0.190 |
Why?
| | Cation Transport Proteins | 1 | 2022 | 109 | 0.180 |
Why?
| | Membrane Transport Modulators | 1 | 2021 | 7 | 0.180 |
Why?
| | Nucleotides | 1 | 2002 | 127 | 0.180 |
Why?
| | Binding Sites | 6 | 2012 | 1313 | 0.180 |
Why?
| | Calcium-Binding Proteins | 1 | 2022 | 215 | 0.170 |
Why?
| | Diastole | 1 | 2021 | 141 | 0.170 |
Why?
| | Alternative Splicing | 1 | 2022 | 227 | 0.160 |
Why?
| | Electrophysiology | 5 | 2011 | 217 | 0.160 |
Why?
| | RNA, Long Noncoding | 1 | 2022 | 171 | 0.160 |
Why?
| | Multigene Family | 1 | 2020 | 201 | 0.160 |
Why?
| | Protein Interaction Domains and Motifs | 1 | 2020 | 150 | 0.160 |
Why?
| | Cells, Cultured | 2 | 2017 | 4181 | 0.140 |
Why?
| | Carrier Proteins | 1 | 2022 | 737 | 0.140 |
Why?
| | Phosphoproteins | 1 | 2020 | 338 | 0.140 |
Why?
| | Sarcolemma | 1 | 2017 | 42 | 0.140 |
Why?
| | Muscle Contraction | 1 | 2000 | 431 | 0.130 |
Why?
| | Bradycardia | 1 | 2017 | 52 | 0.130 |
Why?
| | 1-Methyl-3-isobutylxanthine | 1 | 2017 | 24 | 0.130 |
Why?
| | Colforsin | 1 | 2017 | 48 | 0.130 |
Why?
| | Reference Standards | 1 | 2017 | 184 | 0.130 |
Why?
| | Computer Simulation | 1 | 2021 | 996 | 0.130 |
Why?
| | Phosphodiesterase Inhibitors | 1 | 2017 | 76 | 0.130 |
Why?
| | Potassium Channels, Voltage-Gated | 1 | 2016 | 52 | 0.130 |
Why?
| | Cardiotonic Agents | 1 | 2017 | 95 | 0.120 |
Why?
| | Phosphorylation | 2 | 2011 | 1760 | 0.120 |
Why?
| | AMP-Activated Protein Kinases | 1 | 2017 | 199 | 0.120 |
Why?
| | Amino Acid Sequence | 5 | 2010 | 2155 | 0.120 |
Why?
| | Cloning, Molecular | 2 | 2010 | 533 | 0.120 |
Why?
| | Cellular Reprogramming Techniques | 1 | 2015 | 11 | 0.120 |
Why?
| | Transfection | 3 | 2010 | 941 | 0.120 |
Why?
| | Electric Conductivity | 3 | 2006 | 86 | 0.120 |
Why?
| | rho-Associated Kinases | 1 | 2015 | 84 | 0.110 |
Why?
| | Signal Transduction | 3 | 2024 | 5086 | 0.110 |
Why?
| | Cellular Reprogramming | 1 | 2015 | 98 | 0.110 |
Why?
| | Transgenes | 1 | 2015 | 185 | 0.110 |
Why?
| | Adenoviridae | 1 | 2015 | 200 | 0.110 |
Why?
| | Sodium | 2 | 2013 | 195 | 0.110 |
Why?
| | Male | 6 | 2020 | 68260 | 0.110 |
Why?
| | Immunohistochemistry | 5 | 2015 | 1731 | 0.110 |
Why?
| | Microscopy, Confocal | 4 | 2002 | 324 | 0.110 |
Why?
| | Cell Culture Techniques | 1 | 2016 | 364 | 0.110 |
Why?
| | Humans | 14 | 2024 | 138651 | 0.100 |
Why?
| | Two-Hybrid System Techniques | 3 | 2002 | 57 | 0.100 |
Why?
| | Models, Biological | 1 | 2020 | 1806 | 0.100 |
Why?
| | Heart Atria | 1 | 2013 | 137 | 0.100 |
Why?
| | Transforming Growth Factor beta | 1 | 2015 | 488 | 0.100 |
Why?
| | Time Factors | 3 | 2010 | 6851 | 0.090 |
Why?
| | Gene Expression Regulation | 1 | 2020 | 2590 | 0.090 |
Why?
| | Mutation | 5 | 2017 | 3987 | 0.080 |
Why?
| | Analysis of Variance | 1 | 2013 | 1317 | 0.080 |
Why?
| | Diphosphonates | 1 | 2011 | 69 | 0.080 |
Why?
| | Ligands | 1 | 2012 | 665 | 0.080 |
Why?
| | Electrocardiography | 1 | 2013 | 612 | 0.080 |
Why?
| | Fibroblasts | 1 | 2015 | 1003 | 0.080 |
Why?
| | Protein Structure, Secondary | 2 | 2001 | 367 | 0.080 |
Why?
| | Luminescent Proteins | 2 | 2001 | 181 | 0.080 |
Why?
| | Adrenergic beta-Agonists | 1 | 2010 | 97 | 0.080 |
Why?
| | Rabbits | 2 | 2001 | 747 | 0.080 |
Why?
| | Protein Kinase C | 1 | 2011 | 252 | 0.080 |
Why?
| | Green Fluorescent Proteins | 2 | 2001 | 398 | 0.080 |
Why?
| | Molecular Sequence Data | 3 | 2010 | 2923 | 0.080 |
Why?
| | Reproducibility of Results | 1 | 2017 | 3307 | 0.080 |
Why?
| | Heart Failure | 1 | 2022 | 2067 | 0.080 |
Why?
| | Tandem Mass Spectrometry | 1 | 2010 | 555 | 0.070 |
Why?
| | Mutagenesis, Site-Directed | 3 | 2002 | 375 | 0.060 |
Why?
| | Cadmium | 1 | 2006 | 68 | 0.060 |
Why?
| | Potassium | 2 | 2002 | 147 | 0.050 |
Why?
| | Mutagenesis | 2 | 2002 | 182 | 0.050 |
Why?
| | Protein Kinase Inhibitors | 1 | 2010 | 907 | 0.050 |
Why?
| | Kinetics | 3 | 2002 | 1645 | 0.050 |
Why?
| | DNA, Complementary | 2 | 2002 | 274 | 0.050 |
Why?
| | Fluorescence Resonance Energy Transfer | 1 | 2024 | 173 | 0.050 |
Why?
| | Microscopy, Fluorescence | 2 | 2002 | 414 | 0.050 |
Why?
| | Pyrimidines | 1 | 2006 | 472 | 0.050 |
Why?
| | Disulfides | 1 | 2022 | 97 | 0.050 |
Why?
| | Catecholamines | 1 | 2022 | 91 | 0.050 |
Why?
| | Oligopeptides | 2 | 2001 | 266 | 0.050 |
Why?
| | RNA Splicing Factors | 1 | 2022 | 56 | 0.050 |
Why?
| | Fluorescence | 1 | 2002 | 159 | 0.050 |
Why?
| | Calcium Channels | 1 | 2022 | 156 | 0.040 |
Why?
| | Allosteric Regulation | 1 | 2001 | 89 | 0.040 |
Why?
| | Fluoresceins | 1 | 2001 | 49 | 0.040 |
Why?
| | Mice, Knockout | 2 | 2022 | 3028 | 0.040 |
Why?
| | Chlorine | 1 | 2001 | 61 | 0.040 |
Why?
| | In Situ Hybridization, Fluorescence | 1 | 2022 | 310 | 0.040 |
Why?
| | Surface Properties | 1 | 2002 | 410 | 0.040 |
Why?
| | Organometallic Compounds | 1 | 2001 | 112 | 0.040 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2001 | 553 | 0.040 |
Why?
| | Cysteine | 1 | 2001 | 203 | 0.040 |
Why?
| | Adenosine Triphosphate | 1 | 2022 | 489 | 0.040 |
Why?
| | Calcium Signaling | 1 | 2001 | 250 | 0.040 |
Why?
| | Fluorescent Dyes | 1 | 2001 | 320 | 0.040 |
Why?
| | Arrhythmias, Cardiac | 1 | 2022 | 329 | 0.040 |
Why?
| | Reactive Oxygen Species | 1 | 2022 | 624 | 0.040 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2022 | 462 | 0.040 |
Why?
| | Magnetic Resonance Spectroscopy | 2 | 2017 | 613 | 0.040 |
Why?
| | Cell Membrane | 1 | 2001 | 716 | 0.040 |
Why?
| | Nerve Tissue Proteins | 1 | 2002 | 600 | 0.030 |
Why?
| | Electrocardiography, Ambulatory | 1 | 2017 | 56 | 0.030 |
Why?
| | Microscopy, Electron, Transmission | 1 | 2017 | 157 | 0.030 |
Why?
| | Saccharomyces cerevisiae | 1 | 2001 | 553 | 0.030 |
Why?
| | Neurons | 1 | 2006 | 1601 | 0.030 |
Why?
| | Peptide Fragments | 1 | 2000 | 693 | 0.030 |
Why?
| | Magnetic Resonance Imaging, Cine | 1 | 2017 | 197 | 0.030 |
Why?
| | Physical Endurance | 1 | 2017 | 273 | 0.030 |
Why?
| | GATA4 Transcription Factor | 1 | 2015 | 18 | 0.030 |
Why?
| | MEF2 Transcription Factors | 1 | 2015 | 59 | 0.030 |
Why?
| | Proteins | 1 | 2001 | 1006 | 0.030 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2015 | 136 | 0.030 |
Why?
| | Models, Molecular | 1 | 2000 | 1587 | 0.030 |
Why?
| | Physical Conditioning, Animal | 1 | 2017 | 254 | 0.030 |
Why?
| | T-Box Domain Proteins | 1 | 2015 | 98 | 0.030 |
Why?
| | Embryo, Mammalian | 1 | 2015 | 236 | 0.030 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2015 | 346 | 0.030 |
Why?
| | Sodium-Calcium Exchanger | 1 | 2013 | 16 | 0.030 |
Why?
| | Ion Transport | 1 | 2013 | 60 | 0.030 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 1 | 2015 | 245 | 0.030 |
Why?
| | Fibrosis | 1 | 2015 | 539 | 0.020 |
Why?
| | Sequence Analysis, RNA | 1 | 2015 | 448 | 0.020 |
Why?
| | Blotting, Western | 1 | 2015 | 1230 | 0.020 |
Why?
| | Myocardium | 1 | 2017 | 921 | 0.020 |
Why?
| | Female | 1 | 2019 | 73763 | 0.020 |
Why?
| | Sequence Homology, Amino Acid | 2 | 2002 | 391 | 0.020 |
Why?
| | MicroRNAs | 1 | 2015 | 675 | 0.020 |
Why?
| | Exercise | 1 | 2017 | 2072 | 0.020 |
Why?
| | Cations | 1 | 2002 | 84 | 0.010 |
Why?
| | Nucleotides, Cyclic | 1 | 2002 | 17 | 0.010 |
Why?
| | Indicators and Reagents | 1 | 2001 | 110 | 0.010 |
Why?
| | Calmodulin | 1 | 2001 | 71 | 0.010 |
Why?
| | Spectrometry, Fluorescence | 1 | 2001 | 167 | 0.010 |
Why?
| | Gene Deletion | 1 | 2002 | 388 | 0.010 |
Why?
| | Up-Regulation | 1 | 2002 | 851 | 0.010 |
Why?
| | Protein Conformation | 1 | 2002 | 936 | 0.010 |
Why?
| | Protein Processing, Post-Translational | 1 | 2002 | 462 | 0.010 |
Why?
| | Polymerase Chain Reaction | 1 | 2001 | 1047 | 0.010 |
Why?
| | Recombinant Proteins | 1 | 2001 | 1352 | 0.010 |
Why?
| | Adult | 1 | 2017 | 38201 | 0.010 |
Why?
|
|
Proenza's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|